Table 1 Characteristics of the studied population
Survivors (N = 458) | All causes deaths (N = 886) | P value | |
|---|---|---|---|
Age (y) | 59.2 (12.2) | 64 (13.5) | < 0.001 |
Gender (M), n (%) | 264 (57) | 587 (66) | 0.04 |
SBP (mmHG) | 128.2 (22) | 117 (21) | < 0.001 |
DBP (mmHG) | 74( 12) | 69 (11.5) | < 0.001 |
HR (bpm) | 78( 17) | 85.9 (17) | < 0.001 |
HF etiology n (%) | |||
Ischemic heart disease | 342 (74.6) | 734 (82) | 0.3 |
Valvular heart disease | 41 (8.9) | 94 (10.6) | |
others | 69 (15) | 58 (6.5) | |
Rehospitalizations rate | |||
0–1 | 386 (84) | 633 (71) | |
2 or more | 72 (15) | 253 (28.5) | < 0.001 |
NYHA CLASS n (%) | |||
I–II | 404 (88) | 730 (82) | |
III | 48 (10) | 144 (16) | |
IV | 6 (1) | 10 (1) | 0.68 |
Previous Stroke n (%) | 24 (5) | 32 (3) | |
Previous history of AF n (%) | 104 (22) | 181 (20.2) | |
Hypertension n (%) | 190(41) | 470 (53) | 0.04 |
Diabetes n (%) | 176(37) | 362 (40) | 0.21 |
Menopause n (%) | 168 (36) | 233 (26) | 0.2 |
ESRD n (%) | 88(19) | 51 (5.7) | 0.83 |
Hb (g/dL) | 13.2(2.08) | 11.5 (1.9) | < 0.001 |
Ht (%) | 40 (20.2) | 38 (16.4) | 0.62 |
CRP (mg/L) | 17 (27) | 27 (30) | < 0.001 |
Serum creatinine (mg/dL) | 10.6 (4.2) | 12.39 (4.6) | < 0.001 |
eGFR (ml/min) | 66.3 (13.2) | 54.2 (10.5) | |
Serum Urea (g/L) | 0.48 (0.3) | 0.51 (0.4) | 0.32 |
Serum Sodium (mmol/L) | 137 (3.2) | 137.9 (3.3) | 0.82 |
K (mmol/L) | 4.7(0.8) | 4.9 (0.9) | 0.9 |
AST (U/L) | 24 (9.2) | 27 (8.8) | 0.23 |
ALT (U/L) | 18(6.6) | 23 (7.5) | 0.3 |
LVEF (%), | 36 (9.4) | 35 (9.8) | < 0.001 |
ACEI/ARB n (%) | 379 (82.7) | 681 (76.8) | 0.5 |
Beta-blockers n (%) | 360 (78.6) | 669 (75) | 0.73 |
MRAs n (%) | 200 (43.66) | 340 (38.3) | 0.42 |